Labiana Health S.A.

MC:LAB Spain Drug Manufacturers - Specialty & Generic
Market Cap
$38.54 Million
€37.55 Million EUR
Market Cap Rank
#27988 Global
#105 in Spain
Share Price
€5.20
Change (1 day)
+5.26%
52-Week Range
€2.84 - €5.90
All Time High
€5.90
About

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more

Labiana Health S.A. - Asset Resilience Ratio

Latest as of December 2022: 4.19%

Labiana Health S.A. (LAB) has an Asset Resilience Ratio of 4.19% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€2.54 Million
Cash + Short-term Investments
Total Assets
€60.78 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2022)

This chart shows how Labiana Health S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Labiana Health S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €2.52 Million 4.15%
Short-term Investments €23.38K 0.04%
Total Liquid Assets €2.54 Million 4.19%

Asset Resilience Insights

  • Limited Liquidity: Labiana Health S.A. maintains only 4.19% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Labiana Health S.A. Industry Peers by Asset Resilience Ratio

Compare Labiana Health S.A.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Cronos Group Inc
NASDAQ:CRON
Drug Manufacturers - Specialty & Generic 3.34%
Evoke Pharma Inc
NASDAQ:EVOK
Drug Manufacturers - Specialty & Generic 0.00%
Medical Marijuana I
PINK:MJNA
Drug Manufacturers - Specialty & Generic 0.03%
James E Wagner Cultivation Corp
PINK:JWCAF
Drug Manufacturers - Specialty & Generic 0.00%
CanaQuest Medical Corp
PINK:CANQF
Drug Manufacturers - Specialty & Generic 0.00%
Biostar Pharmaceuticals Inc
PINK:BSPM
Drug Manufacturers - Specialty & Generic 0.00%
Innovativ Media Group Inc
PINK:DMAN
Drug Manufacturers - Specialty & Generic 53.58%

Annual Asset Resilience Ratio for Labiana Health S.A. (2022–2022)

The table below shows the annual Asset Resilience Ratio data for Labiana Health S.A..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 4.19% €2.54 Million €60.78 Million --
pp = percentage points